TPD54_HUMAN - dbPTM
TPD54_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TPD54_HUMAN
UniProt AC O43399
Protein Name Tumor protein D54
Gene Name TPD52L2
Organism Homo sapiens (Human).
Sequence Length 206
Subcellular Localization
Protein Description
Protein Sequence MDSAGQDINLNSPNKGLLSDSMTDVPVDTGVAARTPAVEGLTEAEEEELRAELTKVEEEIVTLRQVLAAKERHCGELKRRLGLSTLGELKQNLSRSWHDVQVSSAYVKTSEKLGEWNEKVTQSDLYKKTQETLSQAGQKTSAALSTVGSAISRKLGDMRNSATFKSFEDRVGTIKSKVVGDRENGSDNLPSSAGSGDKPLSDPAPF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MDSAGQDI
-------CCCCCCCC
9.1920068231
1Sulfoxidation-------MDSAGQDI
-------CCCCCCCC
9.1928465586
3Phosphorylation-----MDSAGQDINL
-----CCCCCCCCCC
32.7628355574
12PhosphorylationGQDINLNSPNKGLLS
CCCCCCCCCCCCCCC
32.7729255136
19PhosphorylationSPNKGLLSDSMTDVP
CCCCCCCCCCCCCCC
32.4529255136
21PhosphorylationNKGLLSDSMTDVPVD
CCCCCCCCCCCCCCC
21.8729255136
22SulfoxidationKGLLSDSMTDVPVDT
CCCCCCCCCCCCCCC
4.4421406390
23PhosphorylationGLLSDSMTDVPVDTG
CCCCCCCCCCCCCCC
37.4829255136
29PhosphorylationMTDVPVDTGVAARTP
CCCCCCCCCHHCCCC
33.5122167270
35PhosphorylationDTGVAARTPAVEGLT
CCCHHCCCCCCCCCC
15.7521815630
42PhosphorylationTPAVEGLTEAEEEEL
CCCCCCCCHHHHHHH
43.96-
50MethylationEAEEEELRAELTKVE
HHHHHHHHHHHHHHH
29.33115918789
55UbiquitinationELRAELTKVEEEIVT
HHHHHHHHHHHHHHH
61.3422053931
55 (in isoform 2)Ubiquitination-61.3421890473
62PhosphorylationKVEEEIVTLRQVLAA
HHHHHHHHHHHHHHH
23.1430576742
70AcetylationLRQVLAAKERHCGEL
HHHHHHHHHHHHHHH
50.0727452117
70SuccinylationLRQVLAAKERHCGEL
HHHHHHHHHHHHHHH
50.0723954790
70UbiquitinationLRQVLAAKERHCGEL
HHHHHHHHHHHHHHH
50.07-
71 (in isoform 6)Phosphorylation-42.8225159151
73 (in isoform 6)Phosphorylation-25.6525159151
78AcetylationERHCGELKRRLGLST
HHHHHHHHHHHCCCH
31.0424847115
80 (in isoform 6)Phosphorylation-31.3620068231
81 (in isoform 6)Phosphorylation-10.5829507054
83 (in isoform 6)Phosphorylation-4.1220068231
84PhosphorylationLKRRLGLSTLGELKQ
HHHHHCCCHHHHHHH
21.5620068231
85PhosphorylationKRRLGLSTLGELKQN
HHHHCCCHHHHHHHH
43.7720068231
90UbiquitinationLSTLGELKQNLSRSW
CCHHHHHHHHHCCCC
32.6021890473
90MethylationLSTLGELKQNLSRSW
CCHHHHHHHHHCCCC
32.6072668545
90UbiquitinationLSTLGELKQNLSRSW
CCHHHHHHHHHCCCC
32.6021890473
90 (in isoform 1)Ubiquitination-32.6021890473
90 (in isoform 2)Ubiquitination-32.6021890473
90 (in isoform 3)Ubiquitination-32.6021890473
90 (in isoform 4)Ubiquitination-32.6021890473
91 (in isoform 6)Phosphorylation-69.5825159151
94PhosphorylationGELKQNLSRSWHDVQ
HHHHHHHCCCCCCHH
31.6423401153
94 (in isoform 2)Phosphorylation-31.6425159151
94 (in isoform 3)Phosphorylation-31.6425159151
94 (in isoform 4)Phosphorylation-31.6425159151
96O-linked_GlycosylationLKQNLSRSWHDVQVS
HHHHHCCCCCCHHCC
25.9530059200
96PhosphorylationLKQNLSRSWHDVQVS
HHHHHCCCCCCHHCC
25.9523927012
96 (in isoform 2)Phosphorylation-25.9525159151
96 (in isoform 3)Phosphorylation-25.9525159151
96 (in isoform 4)Phosphorylation-25.9525159151
103O-linked_GlycosylationSWHDVQVSSAYVKTS
CCCCHHCCEEEEHHH
7.6730059200
103PhosphorylationSWHDVQVSSAYVKTS
CCCCHHCCEEEEHHH
7.6721945579
103 (in isoform 2)Phosphorylation-7.6720068231
103 (in isoform 3)Phosphorylation-7.6720068231
103 (in isoform 4)Phosphorylation-7.6720068231
104O-linked_GlycosylationWHDVQVSSAYVKTSE
CCCHHCCEEEEHHHH
25.4330059200
104PhosphorylationWHDVQVSSAYVKTSE
CCCHHCCEEEEHHHH
25.4321945579
104 (in isoform 2)Phosphorylation-25.4329507054
104 (in isoform 3)Phosphorylation-25.4329507054
104 (in isoform 4)Phosphorylation-25.4329507054
106PhosphorylationDVQVSSAYVKTSEKL
CHHCCEEEEHHHHHH
12.3921945579
106 (in isoform 2)Phosphorylation-12.3920068231
106 (in isoform 3)Phosphorylation-12.3920068231
106 (in isoform 4)Phosphorylation-12.3920068231
108UbiquitinationQVSSAYVKTSEKLGE
HCCEEEEHHHHHHHH
33.3921890473
108 (in isoform 1)Ubiquitination-33.3921890473
108 (in isoform 2)Ubiquitination-33.3921890473
108 (in isoform 3)Ubiquitination-33.3921890473
108UbiquitinationQVSSAYVKTSEKLGE
HCCEEEEHHHHHHHH
33.3921890473
108UbiquitinationQVSSAYVKTSEKLGE
HCCEEEEHHHHHHHH
33.3921890473
112UbiquitinationAYVKTSEKLGEWNEK
EEEHHHHHHHHHCHH
62.6521906983
112 (in isoform 1)Ubiquitination-62.6521890473
114 (in isoform 2)Phosphorylation-49.2825159151
114 (in isoform 3)Phosphorylation-49.2825159151
114 (in isoform 4)Phosphorylation-49.2825159151
119AcetylationKLGEWNEKVTQSDLY
HHHHHCHHCCHHHHH
47.5827452117
119UbiquitinationKLGEWNEKVTQSDLY
HHHHHCHHCCHHHHH
47.58-
119 (in isoform 2)Ubiquitination-47.5821890473
119 (in isoform 3)Ubiquitination-47.5821890473
119 (in isoform 5)Ubiquitination-47.5820972266
121O-linked_GlycosylationGEWNEKVTQSDLYKK
HHHCHHCCHHHHHHH
33.1630059200
123PhosphorylationWNEKVTQSDLYKKTQ
HCHHCCHHHHHHHHH
21.8828152594
126PhosphorylationKVTQSDLYKKTQETL
HCCHHHHHHHHHHHH
18.5425394399
127AcetylationVTQSDLYKKTQETLS
CCHHHHHHHHHHHHH
57.5527452117
127SuccinylationVTQSDLYKKTQETLS
CCHHHHHHHHHHHHH
57.5523954790
128UbiquitinationTQSDLYKKTQETLSQ
CHHHHHHHHHHHHHH
41.7121906983
128 (in isoform 1)Ubiquitination-41.7121890473
129PhosphorylationQSDLYKKTQETLSQA
HHHHHHHHHHHHHHH
27.73-
132PhosphorylationLYKKTQETLSQAGQK
HHHHHHHHHHHHHHH
23.1529396449
134O-linked_GlycosylationKKTQETLSQAGQKTS
HHHHHHHHHHHHHHH
25.9630059200
134PhosphorylationKKTQETLSQAGQKTS
HHHHHHHHHHHHHHH
25.9625159151
139UbiquitinationTLSQAGQKTSAALST
HHHHHHHHHHHHHHH
43.4620972266
139 (in isoform 1)Ubiquitination-43.4621890473
140PhosphorylationLSQAGQKTSAALSTV
HHHHHHHHHHHHHHH
18.7329396449
141PhosphorylationSQAGQKTSAALSTVG
HHHHHHHHHHHHHHH
20.6920068231
144 (in isoform 3)Phosphorylation-4.3924117733
145O-linked_GlycosylationQKTSAALSTVGSAIS
HHHHHHHHHHHHHHH
19.13OGP
145PhosphorylationQKTSAALSTVGSAIS
HHHHHHHHHHHHHHH
19.1325159151
146O-linked_GlycosylationKTSAALSTVGSAISR
HHHHHHHHHHHHHHH
29.72OGP
146PhosphorylationKTSAALSTVGSAISR
HHHHHHHHHHHHHHH
29.7225159151
146 (in isoform 3)Phosphorylation-29.7224117733
146 (in isoform 4)Phosphorylation-29.7225849741
148 (in isoform 3)Phosphorylation-16.0824117733
148 (in isoform 4)Phosphorylation-16.0825849741
149O-linked_GlycosylationAALSTVGSAISRKLG
HHHHHHHHHHHHHHH
20.35OGP
149PhosphorylationAALSTVGSAISRKLG
HHHHHHHHHHHHHHH
20.3525159151
149 (in isoform 3)Phosphorylation-20.3524117733
151 (in isoform 3)Phosphorylation-4.3624117733
152O-linked_GlycosylationSTVGSAISRKLGDMR
HHHHHHHHHHHHCCC
24.07OGP
152PhosphorylationSTVGSAISRKLGDMR
HHHHHHHHHHHHCCC
24.0723401153
155 (in isoform 3)Phosphorylation-7.3624275569
155 (in isoform 4)Phosphorylation-7.3627762562
157 (in isoform 3)Phosphorylation-43.2227135362
157 (in isoform 4)Phosphorylation-43.2225849741
160 (in isoform 4)Phosphorylation-29.3825849741
161PhosphorylationKLGDMRNSATFKSFE
HHHCCCCCCCHHCHH
20.5122167270
163PhosphorylationGDMRNSATFKSFEDR
HCCCCCCCHHCHHHH
31.2729255136
164 (in isoform 3)Phosphorylation-6.6227762562
164 (in isoform 7)Phosphorylation-6.6224117733
165AcetylationMRNSATFKSFEDRVG
CCCCCCHHCHHHHHC
50.2925953088
165MethylationMRNSATFKSFEDRVG
CCCCCCHHCHHHHHC
50.2990159
165UbiquitinationMRNSATFKSFEDRVG
CCCCCCHHCHHHHHC
50.29-
166PhosphorylationRNSATFKSFEDRVGT
CCCCCHHCHHHHHCC
29.6729255136
166 (in isoform 3)Phosphorylation-29.6725849741
166 (in isoform 5)Phosphorylation-29.6725849741
168 (in isoform 5)Phosphorylation-52.5825849741
169 (in isoform 3)Phosphorylation-48.8625849741
169 (in isoform 7)Phosphorylation-48.8624117733
170MethylationTFKSFEDRVGTIKSK
CHHCHHHHHCCCEEE
22.90115918785
171 (in isoform 7)Phosphorylation-14.1824117733
173PhosphorylationSFEDRVGTIKSKVVG
CHHHHHCCCEEEECC
23.5228355574
175 (in isoform 5)Phosphorylation-44.0227762562
176PhosphorylationDRVGTIKSKVVGDRE
HHHCCCEEEECCCCC
27.1721601212
177 (in isoform 5)Phosphorylation-35.6225849741
180 (in isoform 5)Phosphorylation-31.1125849741
184 (in isoform 7)Phosphorylation-57.0427762562
186PhosphorylationVGDRENGSDNLPSSA
CCCCCCCCCCCCCCC
34.6025849741
191PhosphorylationNGSDNLPSSAGSGDK
CCCCCCCCCCCCCCC
35.6723401153
192PhosphorylationGSDNLPSSAGSGDKP
CCCCCCCCCCCCCCC
34.4125159151
195PhosphorylationNLPSSAGSGDKPLSD
CCCCCCCCCCCCCCC
43.4625159151
198UbiquitinationSSAGSGDKPLSDPAP
CCCCCCCCCCCCCCC
51.92-
201PhosphorylationGSGDKPLSDPAPF--
CCCCCCCCCCCCC--
50.5025159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of TPD54_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TPD54_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TPD54_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TPD52_HUMANTPD52physical
9484778
TPD53_HUMANTPD52L1physical
9484778
TPD54_HUMANTPD52L2physical
9484778
TRXR1_HUMANTXNRD1physical
22939629
IPO11_HUMANIPO11physical
22863883
METH_HUMANMTRphysical
22863883
PDIA1_HUMANP4HBphysical
22863883
PFD2_HUMANPFDN2physical
22863883
RAGP1_HUMANRANGAP1physical
22863883
SHLB1_HUMANSH3GLB1physical
22863883
THG1_HUMANTHG1Lphysical
22863883
TPRKB_HUMANTPRKBphysical
22863883
UBQL2_HUMANUBQLN2physical
22863883
SHLB1_HUMANSH3GLB1physical
25416956
CGL_HUMANCTHphysical
26344197
ECHM_HUMANECHS1physical
26344197
HCD2_HUMANHSD17B10physical
26344197
OGT1_HUMANOGTphysical
26344197
PA1B2_HUMANPAFAH1B2physical
26344197
PPM1G_HUMANPPM1Gphysical
26344197
TEBP_HUMANPTGES3physical
26344197
SC31A_HUMANSEC31Aphysical
26344197
SYTC_HUMANTARSphysical
26344197
TRI25_HUMANTRIM25physical
26344197
VAV2_HUMANVAV2physical
26344197
TPD53_HUMANTPD52L1physical
28514442
SHIP2_HUMANINPPL1physical
28514442
TPD52_HUMANTPD52physical
28514442
CSN5_HUMANCOPS5physical
28514442
GABPA_HUMANGABPAphysical
28514442

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TPD54_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-12, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96; SER-149 AND SER-166,AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-12, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-12; SER-21;SER-96 AND SER-166, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12 AND SER-166, AND MASSSPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161; SER-166 ANDTHR-173, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-96 AND SER-166,AND MASS SPECTROMETRY.

TOP